Prostate cancer
Results
Phase 1
This trial found out more about a combination of substances (a compound) that may be used in future in scans to diagnose prostate cancer. The treatment you have for cancer depends on how far it has grown or spread when you are diagnosed (the stage). So it is important that tests or scans give doctors as much information as possible. Scientists have developed a compound called ‘99mTcDB4’, which they hoped would show up prostate cancer more clearly on a scan.
This trial was supported by Cancer Research UK.
Recruitment start: 7 September 2009
Recruitment end: 31 December 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Norbert Avril
Cancer Research UK (Centre for Drug Development)
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
This is Cancer Research UK trial number CRUKD/09/043.
Last reviewed: 06 Oct 2014
CRUK internal database number: 678
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
